Vestibular Rehabilitation After Acute Vertigo: Evidence-Based Perspectives for Clinical Practice

Abstract

Acute vertigo is a prevalent and distressing symptom encountered in clinical practice, often resulting from a spectrum of vestibular disorders. Vestibular rehabilitation (VR) has emerged as a cornerstone in the multidisciplinary management of vertigo, aimed at accelerating central compensation, restoring balance, and enhancing patient quality of life. This review synthesizes current evidence on the epidemiology, pathophysiology, clinical presentation, diagnostic considerations, and contemporary management including the role of VR following acute vertigo. Emphasis is placed on mechanism-based approaches, recent advances, guideline-driven practices, and clinically relevant outcomes to inform healthcare professionals in optimizing patient recovery and functional outcomes.

Introduction

Vertigo, defined as the illusion of movement or spinning, is a cardinal symptom of vestibular dysfunction and represents a significant diagnostic and therapeutic challenge for clinicians. Acute vertigo may arise from peripheral causes such as vestibular neuritis or benign paroxysmal positional vertigo (BPPV), or from central etiologies including cerebrovascular events. The sequelae of acute vertigo persistent imbalance, gaze instability, and reduced activity can profoundly impact patient well-being. Vestibular rehabilitation has gained prominence as an evidence-based therapeutic strategy, facilitating compensation and functional recovery. This review provides an in-depth exploration of VR in the context of acute vertigo, integrating epidemiological data, pathophysiological insights, and guideline recommendations for optimal patient care.

Epidemiology / Disease Burden

Vertigo is a common complaint, with lifetime prevalence estimates ranging from 7% to 30% in the general population. Acute vestibular syndromes, notably vestibular neuritis and BPPV, account for the majority of cases presenting to emergency or primary care settings. The incidence of vestibular neuritis is approximately 3.5 per 100,000, with BPPV affecting 11 to 64 per 100,000 individuals annually. The disease burden extends beyond acute episodes, as recurrent vertigo and chronic vestibular dysfunction contribute to falls, disability, and reduced quality of life, particularly in older adults. The economic impact is substantial, encompassing direct healthcare costs, lost productivity, and long-term care needs.

Pathophysiology

The pathophysiology of acute vertigo typically involves abrupt disruption of normal vestibular function, either peripherally (e.g., inflammation or ischemia of the vestibular nerve in neuritis, dislodged otoconia in BPPV) or centrally (e.g., brainstem or cerebellar lesions). This disruption creates asymmetrical input to the central vestibular nuclei, resulting in vertigo, nystagmus, and postural instability. Central compensation mechanisms including neural plasticity, sensory substitution, and recalibration of vestibulo-ocular and vestibulo-spinal reflexes are critical for recovery. Vestibular rehabilitation leverages these mechanisms by promoting adaptive responses through targeted exercises and activity-based therapy.

Risk Factors

Risk factors for acute vertigo vary by etiology. For vestibular neuritis, viral infections (notably herpes simplex virus), immunocompromised states, and vascular risk factors may predispose individuals. BPPV is more common in older adults, females, and individuals with a history of head trauma, osteoporosis, or prolonged immobilization. Cardiovascular comorbidities, migraine, and certain medications can increase susceptibility to central causes of vertigo. Identifying and addressing modifiable risk factors is essential in both prevention and management.

Clinical Features

Acute vertigo typically presents as sudden-onset spinning or movement sensation, often accompanied by nausea, vomiting, imbalance, and oscillopsia. In vestibular neuritis, vertigo is persistent, severe, and unassociated with hearing loss, while BPPV is characterized by brief, positional episodes triggered by head movements. Central causes may present with additional neurological deficits such as diplopia, dysarthria, or limb weakness. Physical examination findings spontaneous or positional nystagmus, abnormal head thrust test, and impaired balance aid in clinical localization.

Diagnosis

Diagnosis of acute vertigo relies on a thorough history, bedside examination, and targeted investigations. The HINTS (Head-Impulse, Nystagmus, Test-of-Skew) battery distinguishes peripheral from central causes with high sensitivity. Audiometry, vestibular function tests (e.g., caloric testing, video head impulse test), and neuroimaging (MRI) are employed as indicated. Exclusion of life-threatening central pathology, such as posterior circulation stroke, is paramount. Accurate diagnosis guides subsequent management, including appropriateness and timing of VR interventions.

Treatment & Management

Initial management of acute vertigo focuses on symptomatic relief with vestibular suppressants (e.g., antihistamines, benzodiazepines) and antiemetics, used judiciously to avoid hindering compensation. Vestibular rehabilitation is indicated as soon as tolerated, typically within days of onset. VR programs are individualized, incorporating gaze stabilization, habituation, and balance training exercises designed to challenge and retrain the vestibular system. For BPPV, canalith repositioning maneuvers (e.g., Epley, Semont) are highly effective. Multidisciplinary collaboration with physiotherapists and audiologists enhances outcomes. Education, psychological support, and fall prevention strategies are integral to comprehensive care.

Recent Advances / Emerging Therapies

Recent years have seen the development of technology-enhanced VR, including virtual reality-based exercises, computerized dynamic posturography, and home-based tele-rehabilitation platforms. These modalities facilitate patient engagement, objective monitoring, and remote supervision, expanding access to therapy. Research into pharmacological adjuncts (e.g., corticosteroids for vestibular neuritis, vitamin D for BPPV) and neurostimulation approaches (e.g., non-invasive brain stimulation) is ongoing, with promising early results. Precision medicine and individualized rehabilitation protocols are emerging as future directions in VR.

Guideline Recommendations

Current guidelines from the American Academy of Otolaryngology–Head and Neck Surgery and the Barany Society endorse early initiation of VR following acute vestibular events, highlighting its efficacy in accelerating compensation and reducing disability. Canalith repositioning is recommended as first-line therapy for BPPV. Routine use of vestibular suppressants beyond the acute phase is discouraged. Individualized, supervised VR programs tailored to patient deficits and comorbidities are advocated. Ongoing assessment and adjustment of therapy are essential for optimizing outcomes.

Conclusion

Vestibular rehabilitation represents a pivotal, evidence-based intervention in the management of acute vertigo, supporting central compensation, reducing morbidity, and restoring function. Integration of guideline-driven VR into clinical practice, alongside timely diagnosis and multidisciplinary care, can markedly improve recovery trajectories. Continued innovation and research are anticipated to further refine VR strategies, enhance accessibility, and personalize therapy for patients afflicted by acute vestibular syndromes.